Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cardio

Date Submitted: Jan 22, 2018
Open Peer Review Period: Jan 22, 2018 - Aug 14, 2018
Date Accepted: Dec 30, 2018
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Mobile Health for Central Sleep Apnea Screening Among Patients With Stable Heart Failure: Single-Cohort, Open, Prospective Trial

Treskes RW, Maan AC, Verwey HF, Schot R, Beeres SLMA, Tops LF, Van Der Velde ET, Schalij MJ, Slats AM

Mobile Health for Central Sleep Apnea Screening Among Patients With Stable Heart Failure: Single-Cohort, Open, Prospective Trial

JMIR Cardio 2019;3(1):e9894

DOI: 10.2196/cardio.9894

PMID: 31758786

PMCID: 6834232

Mobile health application to screen for central sleep apnea in patients with stable heart failure

  • Roderick Willem Treskes; 
  • Arie C Maan; 
  • Harriette Florence Verwey; 
  • Robert Schot; 
  • Saskia Lambertha Maria Anna Beeres; 
  • Laurens F Tops; 
  • Enno Tjeerd Van Der Velde; 
  • Martin Jan Schalij; 
  • Annelies Margaretha Slats

ABSTRACT

Background:

Polysomnography (PSG) is the gold standard for detection of central sleep apnea (CSA) in stable heart failure (HF) patients. PSG is however costly, time consuming and a burden to the patient and therefore unsuitable as screening method. An E-Health application to measure overnight oximetry may be an acceptable screening alternative.

Objective:

The purpose of this study is therefore to assess if overnight pulse oximetry using a smartphone compatible oximeter can be used to detect CSA in a stable HF population.

Methods:

A total of 26 patients with stable HF underwent one night of both a polygraph (PG) and overnight saturation by a smartphone compatible oximeter. Primary endpoint was the agreement between oxygen desaturation index (ODI) above or below 15 of the smartphone compatible oximeter and the diagnosis of the PG.

Results:

Median age was 66.4 (62-71) years and 92% was male. Body mass index was 27.1 (24.4-30.8) kg•m-2. Seven patients had CSA and 6 patients had obstructive sleep apnea. Of the 7 (.32) patients with CSA that were included in the analysis, 3 (.13) had an ODI≥15. The other 4 (.18) had an ODI<15. Of all patients without CSA, 8 (.36) had an ODI<15. A McNemar’s test yielded a P-Value of .549.

Conclusions:

Oxygen desaturation, when measured by this E-Health application, is a weak predictor of CSA in stable HF patients. Clinical Trial: Not applicable


 Citation

Please cite as:

Treskes RW, Maan AC, Verwey HF, Schot R, Beeres SLMA, Tops LF, Van Der Velde ET, Schalij MJ, Slats AM

Mobile Health for Central Sleep Apnea Screening Among Patients With Stable Heart Failure: Single-Cohort, Open, Prospective Trial

JMIR Cardio 2019;3(1):e9894

DOI: 10.2196/cardio.9894

PMID: 31758786

PMCID: 6834232

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.